Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Barlaa B V is currently prosecuting 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions are distributed across 2 distinct examiners, meaning that each pending application is being reviewed by a different person. This distribution among 2 distinct examiners suggests that the company's current legal strategy must account for the individual styles of multiple examiners.
The workload is also split across 2 distinct art units. This distribution across 2 distinct art units indicates that the company's biotechnology and pharmaceutical innovations are being evaluated by 2 different specialized groups within the USPTO. LI, WENHAN is the busiest examiner for the company, currently responsible for 1 pending office action. Since there are 2 pending office actions in total, the workload is evenly divided between the 2 distinct examiners and the 2 distinct art units. This distribution requires the company to manage its intellectual property across different technical and administrative boundaries.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LI, WENHAN | 1 | — | — |
| CALLAWAY, SPENCER THOMAS | 1 | 35.2% | +18.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19107064 | SILICIC ACID FOR IMPROVING MILK PRODUCTION IN DAIRY LIVESTOCK | LI, WENHAN | — |
| 18561303 | SILICIC ACID IN AQUACULTURE | CALLAWAY, SPENCER THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561303 | SILICIC ACID IN AQUACULTURE | CALLAWAY, SPENCER THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 3642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19107064 | SILICIC ACID FOR IMPROVING MILK PRODUCTION IN DAIRY LIVESTOCK | LI, WENHAN | 1614 | §103§112Other | Non-Final OA | — | Pending | Feb 27, 2025 |
| 18561303 | SILICIC ACID IN AQUACULTURE | CALLAWAY, SPENCER THOMAS | 3642 | §102§103§112 | Non-Final OA | — | Pending | Nov 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBarlaa B V has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Wenhan Li has the most, with 1 of Barlaa B V's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
